APA (7th ed.) Citation

Yanai, H., Adachi, H., Hakoshima, M., Iida, S., & Katsuyama, H. (2024). A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease. MDPI AG.

Chicago Style (17th ed.) Citation

Yanai, Hidekatsu, Hiroki Adachi, Mariko Hakoshima, Sakura Iida, and Hisayuki Katsuyama. A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease. MDPI AG, 2024.

MLA (9th ed.) Citation

Yanai, Hidekatsu, et al. A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease. MDPI AG, 2024.